Bristol Myers Squibb Co stock is traded at $62.14, with a volume of 9,091,782. It is down -1.57% in the last 24 hours and up +4.28% over the past month. Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Previous Close:
$63.13
Open:
$61.46
24h Volume:
9,091,782
Relative Volume:
0.88
Market Cap:
$127.02B
Revenue:
$48.48B
Net Income/Loss:
$7.27B
P/E Ratio:
17.44
EPS:
$3.56
Net Cash Flow:
$11.91B
1W Performance:
-0.54%
1M Performance:
+4.28%
6M Performance:
+9.81%
1Y Performance:
+33.26%
1-Day Range:
$61.32$63.06
1-Week Range:
$61.32$65.54
52-Week Range:
$45.27$68.64
Bristol Myers Squibb Co Stock (BMY) Company Profile
Name
Bristol Myers Squibb CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(609) 252-4621Address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS